Grow your business to best level: Psychiatry 2023

The global neuroscience market reached a value of US$ 32.22 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 41.24 Billion by 2027 exhibiting a CAGR of 3.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Neuroscience Market Trends:

The increasing number of deaths due to various neurological disorders, such as Parkinson's disease, Alzheimer's, schizophrenia, and other brain-related conditions, represents the primary factor driving the market growth. Besides this, the escalating demand for neuroimaging devices and the ongoing brain mapping research and investigation projects are other major growth-inducing factors. Additionally, the governments of various nations are taking favorable initiatives to spread awareness about neurological diseases and the available treatment options. Along with this, the rising usage of microscopy, optogenetics, magnetic resonance imaging (MRI), and electrophysiology instruments in the diagnosis of several neurological disorders is catalyzing the market growth. Furthermore, the leading players are developing innovative medical devices that offer enhanced efficiency and patient compliance to expand their product portfolio and gain a competitive edge. Moreover, the growing awareness regarding the benefits of advanced neuroscience devices, such as the combination of other imaging devices along with the MRI and neuro microscopes over conventional standalone imaging devices, is propelling the market growth. Other factors, including the surging government funding for research and development (R&D) activities, advancements in the field of neuroscience and neuro-technology, increasing healthcare expenditure, rising geriatric population, and improving healthcare infrastructure, are also providing a positive thrust to the market growth.

Psychiatry faces a number of challenges, including the demedicalisation of mental disorder, the marginalisation of psychiatrists and conflicting theoretical orientations for conceptualising mental distress. It affects how we think, feel, and act. It also helps determine how we handle stress, relate to others, and make healthy choices. Longdom Conferences extends immense pleasure in inviting you to join the “5th International Conference on Psychiatry and Behavioural Sciences”. This will be one of the leading Psychiatry conference scheduled in London, UK. These Psychiatry and Behaviour Science Conferences will be focusing on the theme "Emerging Trends for Future of Psychiatry". The aim is to engage, empower, evolve and explore knowledge among both academicians and industry personnel.

Related Conferences: Neuroscince Conferences | Psychology Conferences | Psychiatry Meetings | International Conferences | Medical Meetings | Psychology and Neuroscince Conferences | International Psychiatry Conferences | International Neuroscince Conferences| Behaviour Science conferences | Behaviour Science Meetings